News & Investors

Want to stay updated? Subscribe to our newsletters. For free.

Have questions? Our live support would be happy to help you.

Category: Press Releases

Congressman Donald M. Payne, Jr. Introduces Bipartisan 2016 Colorectal Cancer Detection Act

DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 2016-09-29 / 20:03 The issuer is solely responsible for the content of this announcement. Press release Congressman Donald M. Payne, Jr. Introduces Bipartisan 2016 Colorectal Cancer Detection Act Legislation aims to provide coverage under the Medicare program for FDA-approved qualifying colorectal cancer screening blood-based tests Berlin (Germany) and […]

Read more

Epigenomics AG Announces 2016 Second Quarter and Six Months Financial Results and Reports on Operational Highlights

DGAP-News: Epigenomics AG / Key word(s): Half Year Results 2016-08-10 / 07:30 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG Announces 2016 Second Quarter and Six Months Financial Results and Reports on Operational Highlights – Revenue increased by 159% in Q2 2016 over same period the prior year […]

Read more

Epigenomics AG Confidentially Submits Draft Registration Statement for Potential U.S. Public Offering of ADSs

DGAP-News: Epigenomics AG / Key word(s): IPO 2016-08-10 / 07:00 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG Confidentially Submits Draft Registration Statement for Potential U.S. Public Offering of ADSs Berlin (Germany) and Germantown, MD (U.S.A.), August 10, 2016 – Epigenomics AG today announced that it has confidentially […]

Read more

Epigenomics’ Epi proColon(R) Included in Newly Issued USPSTF Guidelines for Colorectal Cancer Screening

DGAP-News: Epigenomics AG / Key word(s): Miscellaneous 2016-06-16 / 10:15 The issuer is solely responsible for the content of this announcement. Press release Epigenomics’ Epi proColon(R) Included in Newly Issued USPSTF Guidelines for Colorectal Cancer Screening – USPSTF recognizes Epi proColon as the only blood-based colorectal cancer screening test – Convenient and minimal-invasive blood-based testing […]

Read more

Epigenomics AG Announces 2016 First Quarter Financial Results and Reports on Operational Highlights

DGAP-News: Epigenomics AG / Key word(s): Quarterly / Interim Statement 2016-05-23 / 08:00 The issuer is solely responsible for the content of this announcement. Press release Epigenomics AG Announces 2016 First Quarter Financial Results and Reports on Operational HighlightsBerlin (Germany) and Germantown, MD (U.S.A.), May 23, 2016 – Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: […]

Read more

LabCorp is First U.S. Laboratory Network to Offer Epigenomics’ Epi pro Colon(R) Colorectal Cancer Screening Test, Nationally Available Immediately

DGAP-News: Epigenomics AG / Key word(s): Product Launch 2016-05-09 / 14:57 The issuer is solely responsible for the content of this announcement. Press release LabCorp is First U.S. Laboratory Network to Offer Epigenomics’ Epi pro Colon(R) Colorectal Cancer Screening Test, Nationally Available Immediately Berlin (Germany) and Germantown, MD (U.S.A.), May 9, 2016 – Epigenomics AG […]

Read more